Nanopaclitaxel therapy: an evidence based review on the battle for next-generation formulation challenges
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanopaclitaxel therapy: an evidence based review on the battle for next-generation formulation challenges
Authors
Keywords
-
Journal
Nanomedicine
Volume 14, Issue 10, Pages 1323-1341
Publisher
Future Medicine Ltd
Online
2019-05-24
DOI
10.2217/nnm-2018-0313
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paclitaxel-loaded Nanolipidic Carriers with Improved Oral Bioavailability and Anticancer Activity against Human Liver Carcinoma
- (2019) Harshita et al. AAPS PHARMSCITECH
- Paclitaxel: What has been done and the challenges remain ahead
- (2017) Ezequiel Bernabeu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanocarriers in cancer clinical practice: a pharmacokinetic issue
- (2017) Luciana Giodini et al. Nanomedicine-Nanotechnology Biology and Medicine
- Absorption mechanism of DHP107, an oral paclitaxel formulation that forms a hydrated lipidic sponge phase
- (2016) Yura Jang et al. ACTA PHARMACOLOGICA SINICA
- Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study
- (2016) Minish M. Jain et al. BREAST CANCER RESEARCH AND TREATMENT
- A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs
- (2015) C. Khanna et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Design considerations for nanotherapeutics in oncology
- (2015) Triantafyllos Stylianopoulos et al. Nanomedicine-Nanotechnology Biology and Medicine
- Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
- (2015) Nirmala Chandralega Kampan et al. Biomed Research International
- Formulating the magic bullet: barriers to clinical translation of nanoparticle cancer gene therapy
- (2014) William PD Hendricks et al. Nanomedicine
- nab-Paclitaxel: Novel Clinical and Experimental Evidence in Pancreatic Cancer
- (2014) A. Neesse et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Paclitaxel Formulations: Challenges and Novel Delivery Options
- (2014) Chetan Nehate et al. Current Drug Delivery
- Abraxane® versus Taxol® for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective
- (2014) George Dranitsaris et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Engineering the Assemblies of Biomaterial Nanocarriers for Delivery of Multiple Theranostic Agents with Enhanced Antitumor Efficacy
- (2013) Hai Wang et al. ADVANCED MATERIALS
- Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) Formulation and Paclitaxel in Polyethoxylated Castor Oil: A Randomized, Two-Period Crossover Study in Patients With Advanced Cancer
- (2013) Marije Slingerland et al. CLINICAL THERAPEUTICS
- Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery
- (2013) Heebeom Koo et al. JOURNAL OF CONTROLLED RELEASE
- Phase 2 Trial of Paclitaxel Polyglumex with Capecitabine for Metastatic Breast Cancer
- (2012) Donald W. Northfelt et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Antitumor Activity of Triolimus: A Novel Multidrug-Loaded Micelle Containing Paclitaxel, Rapamycin, and 17-AAG
- (2012) J. R. Hasenstein et al. MOLECULAR CANCER THERAPEUTICS
- A dose-finding study with a novel water-soluble formulation of paclitaxel for the treatment of malignant high-grade solid tumours in dogs
- (2012) H. von Euler et al. Veterinary and Comparative Oncology
- Efficacy of taxanes as adjuvant treatment of breast cancer: a review and meta-analysis of randomised clinical trials
- (2011) Jordi Ginés et al. Clinical & Translational Oncology
- Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid Tumors
- (2011) R. Kurzrock et al. MOLECULAR CANCER THERAPEUTICS
- Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
- (2010) A. Chan et al. ANNALS OF ONCOLOGY
- Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma
- (2010) A. Y. Bedikian et al. ANNALS OF ONCOLOGY
- Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice
- (2010) Lukas W. Pfannenstiel et al. CELLULAR IMMUNOLOGY
- Phase I and Pharmacokinetic Study of ABI-007, Albumin-bound Paclitaxel, Administered Every 3 Weeks in Japanese Patients with Solid Tumors
- (2010) K. Yamada et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 open-label study of weekly docosahexaenoic acid–paclitaxel in patients with metastatic uveal melanoma
- (2010) Jade Homsi et al. MELANOMA RESEARCH
- Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
- (2010) A. Ganguly et al. MOLECULAR CANCER THERAPEUTICS
- Vascular targeting by EndoTAG™-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer
- (2009) Martin E. Eichhorn et al. INTERNATIONAL JOURNAL OF CANCER
- Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer
- (2009) Won Deok Joo et al. Journal of Gynecologic Oncology
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies
- (2008) Paula M. Fracasso et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel
- (2008) E. R. Gardner et al. CLINICAL CANCER RESEARCH
- Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer
- (2008) Martine J. Piccart-Gebhart et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started